Corrigendum to: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study).

Shimomura, Akihiko; Tamura, Kenji; Tanaka, Kiyo; Mizutani, Tomonori; Sasaki, Keita; Sekino, Yuta; Sawaki, Masataka; Shien, Tadahiko; Shibata, Taro; Iwata, Hiroji

Shimomura, Akihiko; Tamura, Kenji; Tanaka, Kiyo; Mizutani, Tomonori; Sasaki, Keita; Sekino, Yuta; Sawaki, Masataka; Shien, Tadahiko; Shibata, Taro; Iwata, Hiroji.

Afiliação

Shimomura A; Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
Tamura K; Department of Medical Oncology, Shimane University Hospital, Shimane, Japan.
Tanaka K; Department of Breast and Endocrine Surgery, Toranomon Hospital, Tokyo, Japan.
Mizutani T; Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.
Sasaki K; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
Sekino Y; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
Sawaki M; Department of Breast Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
Shien T; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama Japan.
Shibata T; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Aichi, Japan.

Jpn J Clin Oncol ; 51(9): 1479, 2021 Aug 30.

Article em En | MEDLINE | ID: mdl-34296283

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Jpn J Clin Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google